| 1 |
31489252 | Metformin inhibits cervical cancer cell proliferation via decreased AMPK O-GlcNAcylation. | 2019 |
1 |
| 2 |
27600020 | Activation of AMPK α2 inhibits airway smooth muscle cells proliferation. | 2016 Nov 15 |
2 |
| 3 |
25955843 | Metformin Causes G1-Phase Arrest via Down-Regulation of MiR-221 and Enhances TRAIL Sensitivity through DR5 Up-Regulation in Pancreatic Cancer Cells. | 2015 |
1 |
| 4 |
24809794 | Activation of AMPK inhibits pulmonary arterial smooth muscle cells proliferation. | 2014 Jun |
1 |
| 5 |
24858012 | Metformin induces apoptosis and cell cycle arrest mediated by oxidative stress, AMPK and FOXO3a in MCF-7 breast cancer cells. | 2014 |
1 |
| 6 |
22773548 | Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies. | 2013 Apr |
1 |
| 7 |
23974492 | Metformin inhibits lung cancer cells proliferation through repressing microRNA-222. | 2013 Dec |
1 |
| 8 |
22421144 | Metformin suppresses growth of human head and neck squamous cell carcinoma via global inhibition of protein translation. | 2012 Apr 1 |
1 |
| 9 |
22593441 | Metformin and the mTOR inhibitor everolimus (RAD001) sensitize breast cancer cells to the cytotoxic effect of chemotherapeutic drugs in vitro. | 2012 May |
1 |
| 10 |
19440038 | Metformin induces unique biological and molecular responses in triple negative breast cancer cells. | 2009 Jul 1 |
1 |